AVAC‘s 13th annual report, Turning the Page surveys, critiques and proposes recommendations for the field of biomedical prevention research: AIDS vaccines, microbicides and ARV-based prevention strategies such as PrEP and treatment as prevention.

As the report describes, scientific developments in several arenas of biomedical prevention research have re-energized the search for additional strategies. In the vaccine field this includes the first evidence of vaccine-induced protection and strides in identification of new potent, HIV-specific neutralizing antibodies. Antiretroviral-based prevention also shows potential, and the report provides context for the upcoming results of the CAPRISA 004 microbicide trial, the first effectiveness trial of an ARV-based prevention strategy in HIV-negative people.

For the full report click here.